Gene Editing Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines Posted on May 4, 2022 by Editorial Staff Scientists have discussed the possibilities of developing oral replicon-based mRNA vaccines against SARS-CoV-2. Share on FacebookTweetFollow us Editorial Staff STAT+: Pharmalittle: Biogen is perilously poised for the future; WTO advances controversial Covid-vaccine patent waiver Study explores long COVID in adults